Moderna MRNA Balance Sheet Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $2.6B+34.6% | $1.93B-34.1% | $2.93B-9.0% | $3.22B-53.1% | ||
| $3.2B-37.2% | $5.1B-10.5% | $5.7B-14.9% | $6.7B+72.6% | ||
| $184M-48.6% | $358M-59.9% | $892M-35.6% | $1.39B-56.4% | ||
| $490M-6.0% | $521M-73.7% | $1.98B-71.1% | $6.85B+93.3% | ||
| $6.54B-19.2% | $8.1B-21.6% | $10.33B-23.1% | $13.43B-16.4% | ||
| $2.13B-2.8% | $2.2B+12.9% | $1.95B-3.6% | $2.02B+62.6% | ||
| $52M0.0% | $52M0.0% | $52M— | $0— | ||
| $45M+12.5% | $40M-9.1% | $44M— | $0— | ||
| $12.34B-12.8% | $14.14B-23.2% | $18.43B-28.7% | $25.86B+4.8% | ||
| $317M-21.7% | $405M-22.1% | $520M+6.8% | $487M+61.3% | ||
| $99M-35.3% | $153M-73.1% | $568M-72.1% | $2.04B-67.4% | ||
| $25M+8.7% | $23M— | $0-100% | $161M-2.4% | ||
| $1.99B-9.9% | $2.21B-26.8% | $3.02B-38.8% | $4.92B-46.1% | ||
| $590M— | $0— | —— | —— | ||
| $3.69B+13.8% | $3.24B-29.1% | $4.57B-32.1% | $6.74B-36.0% | ||
| 1.6B— | 0— | 0— | 0— | ||
| $7.22B-28.1% | $10.05B-26.2% | $13.61B-25.7% | $18.32B+84.0% | ||
| $8.65B-20.6% | $10.9B-21.3% | $13.85B-27.6% | $19.12B+35.2% | ||
| $12.34B-12.8% | $14.14B-23.2% | $18.43B-28.7% | $25.86B+4.8% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Moderna's total assets?
- Moderna (MRNA) holds $11.5B in total assets, down 9.6% year over year.
- How much debt does Moderna have?
- Moderna carries $1.3B in total debt against $7.4B of shareholders' equity, a debt-to-equity ratio of 0.18.
- How much cash does Moderna have?
- Moderna holds $1.9B in cash and equivalents.
- Can Moderna cover its short-term obligations?
- Its current ratio is 2.41 — current assets exceed current liabilities.
- Where does Moderna's balance sheet data come from?
- Every line is extracted from Moderna's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
